Furthermore, diabetic glucose tolerance curves were classified into two groups , according to the fasting blood glucose levels, mild diabetes (Dl) with the blood glucose level less than 120mg/100ml, and moderate (D2) with the blood glucose level of 120 to 180 mg/100ml . Abnormal glucose tolerance curves were divided as follows: retarded type (R) in which only a 2-hr glucose level exceeded 140mg/100ml
, oxyhyperglycemia (O) in which only the peak level exceeded 160mg/100ml, and renal glycosuria (RG). The mean value and the standard error of mean were calculated and statistical analyses were performed by Student's t-test.
RESULTS
Changes of glucose tolerance in subclinical diabetic subjects GTT was carried out at least twice in 121 cases of subclinical diabetes for one to fifteen years, and the results obtained during the course were compared with those of GTT at the first visit. In 89 out of 121 subclinical cases (73%) , GTT was repeated at an interval of two years or more. Initial glucose tolerance test. Glucose tolerance curves obtained at the first visit were divided as follows: D2 (29 cases), D1 (80 cases), R (8 cases), 0 (2 cases), RG (1 case) and normal (N, 1 case). The patient with normal GTT was included because of diabetic microangiopathy of the retina. Therefore, diabetic glucose tolerance curves were observed in 109 patients (80%) with subclinical diabetes.
Changes of glucose tolerance performed at different intervals. GTT was carried out in 48 patients one year after the first visit. The changes of glucose tolerance curves are presented in Table 1 . Glucose tolerance was improved in 28 patients, while it was deteriorated in only 3 patients. In the other 17 patients, glucose tolerance did not change.
GTT was performed 2 to 3 years after the first visit in 60 patients. The results are shown in Table 2 . An improvement in glucose tolerance was observed in 41 patients and an aggravation in only 2 patients. The rest 17 patients revealed the similar glucose tolerance to the initial one.
The changes in glucose tolerance test performed in 4 to 5 years are presentea in Final glucose tolerance. A comparison of glucose tolerance curves between the initial and final visit is presented in Table 5 . In the final GTT , 8 patients (7%) revealed D2, 54 patients (45%) Dl and 37 patients (31%) R . Oxyhyperglycemia (0), renal glycosuria (RG) and normal glucose tolerance curves were observed in 8 (7%), 1 (1%), and 13 patients (11%), respectively . Therefore, glucose tolerance was improved in 61 patients and remained unchanged in 53 patients . Deterioration of glucose tolerance was observed in only 7 patients .
Insulin response in GTT
Insulin response to oral glucose load was investigated in 74 patients with subclinical diabetes. The changes in glucose tolerance of these patients are summarized in Table 6 . The final glucose tolerance in these patients revealed D2 in 6, D1 in 34, R in 18, 0 in 7 and normal glucose tolerance in 9 patients . An improvement in glucose tolerance was observed in 39 patients (53%) , while it remained unchanged in 30 patients (41%). Five patients showed a deterioration in glucose tolerance.
The mean values of blood glucose and plasma insulin in GTT are presented in Fig . 1 . Insulin response in both groups D2 and D1 was decreased, but the levels of plasma insulin at the later period were higher in these groups than in the normal controls. The group R revealed a delayed response of plasma insulin.
The levels of plasma insulin were slightly elevated in the group 0 at 30, 60 and 90 Klimt et al. 1967 ). The cut-off points in these criteria were drawn arbitrarily and they are distributed widely as seen in the report of West (1975) who published the answers from 20 diabetologists in response to his questionnaire. In Japan, the criterion of glucose tolerance for the diagnosis of diabetes mellitus, which was recommended by the Committee of Japan Diabetes Society (CJDS), has been widely employed (Kuzuya 1970) . In order to elucidate the validity of the criterion for diabetes mellitus, 121 patients, who showed diabetic or abnormal glucose tolerance according to the criterion recommended by CJDS, were selected as subclinical diabetes in the present study.
During their clinical courses, only 7 patients deteriorated in glucose tolerance and 6 patients developed overt diabetes. Such a low incidence in development to overt diabetes from subclinical diabetes was reported by several authors (O'Sullivan and Mahan 1968; Fajans et al. 1973; Rosenbloom et al. 1973; Logie et al. 1974 ). These results might suggest that the patients in the present study were not mild type of overt diabetes. However, their clinical course did not reflect the natural history of diabetes mellitus, because they were treated with diet, as observed by Logie et al. (1974) . In contrast, much higher incidence of deterioration in glucose tolerance was reported in the patients group, which revealed chemical diabetes and was not treated for several years (Ito and Kawate 1976) . On the other hand, normal glucose tolerance was scarcely obtained in patients who revealed diabetic glucose tolerance at the first visit in the present study. Even if their glucose tolerance was improved, glucose tolerance curves still remained at Dl, R or 0 type. Furthermore, 58 out of 74 cases of subclinical diabetes, in which insulin response to glucose load was investigated, showed impaired insulin response. Normal insulin response to oral glucose was observed in only 13 patients. In addition, diabetic retinopathy was observed in 25 of 109 patients (23%) who showed diabetic glucose tolerance. This figure observed in patients with slightly decreased glucose tolerance might be considered relatively high in comparison with the incidence of retinopathy in overt diabetes. These results indicate that the subclinical diabetes studied in the present investigation was a mild type of primary diabetes and support the validity of the criterion for the diagnosis of diabetes mellitus recommended by CJDS.
It is acknowledged that diabetes mellitus is characterized by a decrease in insulin effect. As far as the plasma concentration of immunoassayable insulin is concerned, this does not always reach a concordance. A number of studies demon strated an impairment of initial secretion in diabetes mellitus (Seltzer et al . 1967 Johansen (1972) observed the same insulin response to glucose in mild diabetes as in normal controls. The present study demonstrated that insulin response to glucose in subclinical diabetes is different from that in the normal subjects. Groups D2 and D1 revealed low and/or delayed response to oral glucose, whereas group R showed delayed response. Decreased and/or delayed response of the initial phase of insulin secretion were demonstrated in 58 out of 74 subclinical diabetics (78%). Such an abnormality in insulin secretion was also observed in the subclinical diabetes in response to glucose or glucagon following tolbutamide injection, as previously reported (Ohneda et al . 1977 ). These results indicate that insulin response to glucose or glucagon is impaired even in the subclinical diabetes.
Diabetic retinopathy is presumed as one of the pathognomonic findings for diabetes mellitus. Thirteen of 16 cases of subclinical diabetes (80%) complicated with diabetic retinopathy revealed a decreased and/or delayed response of plasma insulin to oral glucose. This result is also consistent with the hypothesis that impaired insulin secretion is one of the early findings of diabetes mellitus .
